Vertex Pharmaceuticals | VRTX - Interest Income

Stock Price
470.52
Daily Change
4.91 1.05%
Monthly
4.84%
Yearly
-3.67%
Q1 Forecast
455.43

Vertex Pharmaceuticals reported $122.4M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Gilead Sciences USD 73M 21M Jun/2025
Incyte USD 25.14M 2.21M Jun/2025
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.12 0.17 Sep/2025
Merck USD 96M 27M Sep/2025
Moderna USD 81M 9M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025